NCT02830217View on ClinicalTrials.gov

Evaluation of Soluble ST2 in Patients Receiving Primary PCI With ST-elevation Myocardial Infarction

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

November 30, 2018

Study Completion Date

December 20, 2018

Conditions
Myocardial InfarctionShock
Trial Locations (1)

430022

Wuhan Asia Heart Hospital, Wuhan

All Listed Sponsors
lead

Wuhan Asia Heart Hospital

OTHER

NCT02830217 - Evaluation of Soluble ST2 in Patients Receiving Primary PCI With ST-elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter